Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00YWP
|
|||
| Former ID |
DAP000903
|
|||
| Drug Name |
Nandrolone
|
|||
| Synonyms |
Decadura; Estrenolone; Menidrabol; Nadrolone; Nandrolon; Nandrolona; Nandrolonum; Norandrostenolon;Norandrostenolone; Nortestonate; Nortestosterone; Nortestosteronum; Oestrenolon; LT03330030; U 2410; Decadura (TN); Durabolin (TN); Nandrolona [INN-Spanish]; Nandrolone (INN); Nandrolonum [INN-Latin]; Estr-4-en-3-one, 17beta-hydroxy-(8CI); Estr-4-en-3-one, 17-hydroxy-, (17beta)-(9CI); Estr-4-en-3-one, 17-hydroxy-, (17-beta)-(9CI); (17-beta)-17-Hydroxyestr-4-en-3-one; (17beta)-17-hydroxyestr-4-en-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one; 17-Hydroxy-Estr-4-Ene-3-One; 17-beta-Hydroestr-4-en-3-one; 17beta-Hydroxy-19-nor-4-androsten-3-one; 17beta-Hydroxy-19-norandrost-4-en-3-one; 17beta-Hydroxy-4-estren-3-one; 17beta-hydroxy-19-nor-4-androsten-3-one; 17beta-hydroxy-4-estren-3-one; 17beta-hydroxyestr-4-en-3-one; 19-Norandrostenolone; 19-Nortestosterone; 4-Estren-17beta-ol-3-one; 4-estren-17beta-ol-3-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Osteoporosis [ICD-11: FB83.0; ICD-10: M85.8; ICD-9: 733] | Approved | [1], [2] | |
| Therapeutic Class |
Anabolic Agents
|
|||
| Company |
Aspen Global Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H26O2
|
|||
| Canonical SMILES |
CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34
|
|||
| InChI |
1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1
|
|||
| InChIKey |
NPAGDVCDWIYMMC-IZPLOLCNSA-N
|
|||
| CAS Number |
CAS 434-22-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9463, 7980080, 8157151, 12146096, 14718104, 14771089, 24870216, 24886700, 24897817, 29215354, 29228461, 46386764, 48416309, 49965900, 50531284, 53788175, 57325858, 57650818, 57652521, 83613872, 85148374, 85300761, 92308394, 92714065, 96024938, 103202464, 103980273, 104321851, 121363640, 124658841, 124813376, 124892176, 126524638, 126624424, 126655692, 126688604, 128733950, 134338180, 134974495, 137006447, 144089075, 144206718, 144206750, 144208410, 152034352, 162222852, 163686430, 164763232, 164788571, 170466348
|
|||
| ChEBI ID |
CHEBI:7466
|
|||
| ADReCS Drug ID | BADD_D01529 | |||
| SuperDrug ATC ID |
A14AB01; S01XA11
|
|||
| SuperDrug CAS ID |
cas=000434220
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6949). | |||
| REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
| REF 3 | Expression of androgen receptor on fibroblast and hepatocyte of rats after deep second-degree burn caused by scalding. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 May;36(3):362-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.